These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Letter to the Editor: "Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men". Asadipooya K. J Clin Endocrinol Metab; 2019 Mar 01; 104(3):682-683. PubMed ID: 30351352 [No Abstract] [Full Text] [Related]
7. Endogenous Secretory Receptor for Advanced Glycation End Products Protects Endothelial Cells from AGEs Induced Apoptosis. Yang G, Huang Y, Wu X, Lin X, Xu J, Chen X, Bai X, Li Q. Biomed Res Int; 2018 Mar 01; 2018():8216578. PubMed ID: 29850572 [Abstract] [Full Text] [Related]
10. Letter to editor about "Effects of nutritional intervention upon bone turnover in elderly hip fracture patients. Randomized controlled trial". Heidari ME, Dezvarei Z. Clin Nutr ESPEN; 2019 Aug 01; 32():166. PubMed ID: 31221285 [No Abstract] [Full Text] [Related]
15. Variables Affecting the Level of Soluble Receptor for Advanced Glycation End Products. Son KH, Choi CH, Park CH. Ann Thorac Surg; 2017 Nov 01; 104(5):1755. PubMed ID: 28163039 [No Abstract] [Full Text] [Related]
16. Extracellular matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer. Rojas A, Añazco C, González I, Araya P. Carcinogenesis; 2018 Apr 05; 39(4):515-521. PubMed ID: 29373651 [Abstract] [Full Text] [Related]
18. Microplate-based Assay for Screening of Advanced Glycation End Products Binding to Its Receptor. Ganesh D, Torigoe K, Kumano-Kuramochi M, Machida S, Kobori T. Anal Sci; 2019 Mar 10; 35(3):237-240. PubMed ID: 30643096 [Abstract] [Full Text] [Related]